Mestastop Solutions raises Rs. 1.3 Cr in round led by CIIE.CO
Biotech startup Mestastop recently raised Rs, 1.3 core in funding in a round led by CIIE.CO. The round also saw participation from IKP Knowledge Park and a clutch of angel investors.
The company plans to use the capital raised for scaling its AI-based platform METSCAN and running PoC animal model studies to validate proof of concept for cancer drug discovery and repurposing.
Founded in 2018 by Dr. Arnab Roy Chowdhury and Dr. Debabani Roy Chowdhury, the Bengaluru-based platform aims to revolutionise cancer treatment using wet lab biology and predictive analytics to detect properties of metastasis and utilise them for drug discovery and patient treatment.
“An evolutionary disease like cancer cannot be holistically targeted without targeting metastasis, a process that is complex and is yet to be fully understood. We have successfully created tools and platforms to decipher this biology, translated it with patient data, and then into animal models completing our first phase,” stated Dr Arnab Roy Chowdhury, founder and CEO of Mestastop. He further added, “Now, we endeavour on the bigger journey of using these tools for first-in-class metastasis drug discovery and predictive diagnostics, that will give terminal cancer patients a second shot at life, further reinforcing India’s image as one of the pioneering innovation hubs in the Biotech world.”
Follow Startup Story
Related Posts
